Paper

Tree Display

AceDB Schema

XML Display

Feedback

Paper Report for: Visanji_2006_Neuropharmacol_51_506

Reference

Title: Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle
Visanji NP, O'Neill MJ, Duty S
Ref: Neuropharmacology, 51:506, 2006 : PubMed

        



Related information



Citations formats

Visanji NP, O'Neill MJ, Duty S (2006)
Nicotine, but neither the alpha4beta2 ligand RJR2403 nor an alpha7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle
Neuropharmacology 51: 506-16

Visanji NP, O'Neill MJ, Duty S (2006)
Neuropharmacology 51: 506-16



Send your questions or comments to :
Mail to: Nicolas Lenfant, Thierry Hotelier, Yves Bourne, Pascale Marchot and Arnaud Chatonnet.
Please cite: Lenfant 2013 Nucleic.Acids.Res. or Marchot Chatonnet 2012 Prot.Pept Lett.
For technical information about these pages see:
ESTHER Home Page and ACEDB Home Page
AcePerl Lincoln Stein Home Page
webmaster

Acknowledgements and disclaimer